Loading...
| A03285 | Pages: NA | Dec 2021 | 4462 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Europe Drug Coated Endotracheal Tube Market
Request Now !Endotracheal tube is a catheter introduced in the trachea to confirm the adequate exchange of oxygen and carbon dioxide and maintains the patients airway. Drug coated endotracheal tube is a specific tube coated with drug such as polyvinyl chloride and is nearly always inserted through the mouth or nose.
The major factor that contributes to the growth of the European drug coated endotracheal tube market includes rise in number of chronic respiratory diseases such as cardiovascular diseases, respiratory diseases, diabetes, cancer, and other lung injuries. Moreover, increase in geriatric population, who are more prone to chronic diseases, and development in R&D activities also boost the market growth. However, stringent approval process hamper the market growth. The development of novel products by key vendors, mainly to avoid ventilator-associated pneumonia (VAP) condition by preventing bacterial colonization and biofilm formation on tube surface, further provide lucrative growth opportunities for the market.
European drug coated endotracheal tube market is segmented on the basis of type, coating type, application, end user, and country. Based on type, it is divided into oral or nasal tube, cuffed or uncuffed tube, preformed tube, reinforced tube, and double-lumen endobronchial tube. Based on coating type, it is segmented into antithrombotic drug coated, and antiproliferative drug coated. On the basis of application, the market is categorized into benign prostatic hyperplasia (BPH), ureteral stenosis, prostatic cancer, esophageal stricture, sinus stenosis, and biliary stricture. On the basis of end user, the market is classified into hospital, medical center, and others (clinics and ambulatory surgical centers). By country, the market is analyzed across Germany, France, UK, Italy, Spain, and rest of Europe.
The key players operating in the market include Teleflex Corporation, C. R. Bard, Inc., AirWay Technologies, Inc., Allvivo Vascular, Inc., BRIO DEVICE LLC, Medtronic, Smiths Group plc, Becton, Dickinson and Company, Enox Biopharma, Inc, and Merit Medical Systems, Inc.
Key Benefits
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTERS FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
CHAPTER 4 EUROPE DRUG COATED ENDOTRACHEAL TUBE MARKET, BY TYPE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. ORAL OR NASAL TUBE
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. CUFFED OR UNCUFFED TUBE
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.4. PREFORMED TUBE
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
4.5. REINFORCED TUBE
4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast
4.6. DOUBLE-LUMEN ENDOBRONCHIAL TUBE
4.6.1. Key market trends
4.6.2. Growth factors and opportunities
4.6.3. Market size and forecast
CHAPTER 5 EUROPE DRUG COATED ENDOTRACHEAL TUBE MARKET, BY COATING TYPE
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. ANTITHROMBOTIC DRUG COATED
5.2.1. Market size and forecast
5.3. ANTIPROLIFERATIVE DRUG COATED
5.3.1. Market size and forecast
CHAPTER 6 EUROPE DRUG COATED ENDOTRACHEAL TUBE MARKET, BY APPLICATION
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. BENIGN PROSTATIC HYPERPLASIA (BPH)
6.2.1. Market size and forecast
6.3. URETERAL STENOSIS
6.3.1. Market size and forecast
6.4. PROSTATIC CANCER
6.4.1. Market size and forecast
6.5. ESOPHAGEAL STRICTURE
6.5.1. Market size and forecast
6.6. SINUS STENOSIS
6.6.1. Market size and forecast
6.7. BILIARY STRICTURE
6.7.1. Market size and forecast
CHAPTER 7 EUROPE DRUG COATED ENDOTRACHEAL TUBE MARKET, BY END USER
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. HOSPITALS
7.2.1. Market size and forecast
7.3. MEDICAL CENTERS
7.3.1. Market size and forecast
7.4. OTHERS
7.4.1. Market size and forecast
CHAPTER 8 EUROPE DRUG COATED ENDOTRACHEAL TUBE MARKET, BY COUNTRY
8.1. OVERVIEW
8.2. KEY MARKET TRENDS
8.3. KEY GROWTH FACTORS AND OPPORTUNITIES
8.4. MARKET SIZE AND FORECAST
8.4.1. Germany market size and forecast
8.4.2. France market size and forecast
8.4.3. UK market size and forecast
8.4.4. Italy market size and forecast
8.4.5. Spain market size and forecast
8.4.6. Rest of Europe market size and forecast
CHAPTER 9 COMPANY PROFILES
9.1. TELEFLEX CORPORATION
9.1.1. Operating business segments
9.1.2. Business performance
9.1.3. Key strategic moves and developments
9.2. C. R. BARD, INC.
9.2.1. Operating business segments
9.2.2. Business performance
9.2.3. Key strategic moves and developments
9.3. AIRWAY TECHNOLOGIES, INC.
9.3.1. Operating business segments
9.3.2. Business performance
9.3.3. Key strategic moves and developments
9.4. ALLVIVO VASCULAR, INC.
9.4.1. Operating business segments
9.4.2. Business performance
9.4.3. Key strategic moves and developments
9.5. BRIO DEVICE LLC
9.5.1. Operating business segments
9.5.2. Business performance
9.5.3. Key strategic moves and developments
9.6. MEDTRONIC PLC.
9.6.1. Operating business segments
9.6.2. Business performance
9.6.3. Key strategic moves and developments
9.7. SMITHS GROUP PLC.
9.7.1. Operating business segments
9.7.2. Business performance
9.7.3. Key strategic moves and developments
9.8. BECTON, DICKINSON AND COMPANY
9.8.1. Operating business segments
9.8.2. Business performance
9.8.3. Key strategic moves and developments
9.9. ENOX BIOPHARMA, INC.
9.9.1. Operating business segments
9.9.2. Business performance
9.9.3. Key strategic moves and developments
9.10. MERIT MEDICAL SYSTEMS, INC.
9.10.1. Operating business segments
9.10.2. Business performance
9.10.3. Key strategic moves and developments
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
10%
Discount
10%
Discount
10%
Discount
10%
Discount
Enterprise
License/PDF
10%
Discount
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
